Neuromodulation in Neuro-Oncology: A Scoping Review
Journal of Personalized Medicine · 28.06.2026 · 16 (7) · 349
DOI: 10.3390/jpm16070349 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 28.06.2026. Verfasst von Ahmad I Kamaludin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurosurgery, King's College Hospital, London SE5 9RS, UK. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neuromodulation is a rapidly developing field with growing interest in its application in neuro-oncology, particularly since the publication of the EF-14 trial which demonstrated a survival benefit conferred by tumour treating fields (TTF) in patients with glioblastoma. In addition, the emerging field of cancer neuroscience has postulated the role of neural–tumour communication in tumour aetiology, which is theoretically targetable by neuromodulation strategies. This scoping review therefore aims to comprehensively evaluate current or future applications of neuromodulation in managing patients with brain tumours, encompassing preclinical and clinical studies.
Methods
The MEDLINE database was queried for all relevant articles from inception to 1 December 2024. A synthesis of findings was performed, broadly categorised to preclinical and clinical research.
Findings
The database search returned 3296 results, from which 187 full-text articles were further assessed. A total of 79 studies met the inclusion and exclusion criteria and were included. The results from preclinical studies (n = 18) were stratified according to modality which included electrical therapy, electroporation, electromagnetic field (EMF) and deep brain stimulation (DBS). Similarly, clinical studies (n = 61) were classified to preoperative modalities such as transcranial magnetic stimulation (TMS) and transcranial direct stimulation (tDCS), and postoperative modalities such as TMS, TTF, EMF and spinal cord stimulation (SCS).
Interpretation
The application of neuromodulation as adjunctive therapy in the context of neuro-oncology is an emerging field, with encouraging results in various modalities across a wide range of applications from surgical planning and functional rehabilitation, to its therapeutic potential. Further research is urgently needed to harness the potential of neuromodulation in improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Neurosurgery, King's College Hospital, London SE5 9RS, UK.
- National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
ORCID-Profile: Ashwin Kumaria
Zitieren
APA
Kamaludin, A. I., Kumaria, A., & Ashkan, K. (2026). Neuromodulation in Neuro-Oncology: A Scoping Review. Journal of Personalized Medicine, 16(7), 349. https://doi.org/10.3390/jpm16070349
Vancouver
Kamaludin AI, Kumaria A, Ashkan K. Neuromodulation in Neuro-Oncology: A Scoping Review. Journal of Personalized Medicine. 2026;16(7):349. doi:10.3390/jpm16070349
BibTeX
@article{Kamaludin2026,
author = {Kamaludin, Ahmad I and Kumaria, Ashwin and Ashkan, Keyoumars},
title = {Neuromodulation in Neuro-Oncology: A Scoping Review},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {7},
pages = {349},
doi = {10.3390/jpm16070349}
}
EUVIMED